Treatment options include a full range of the most up-to-date chemotherapeutic and biologic therapies. The Monter Cancer Center promotes active participation in clinical trials and offers access to national cooperative group trials through our unique position as founding members of the prestigious National Cancer Institute Community Clinical Oncology Program (CCOP). The center is a main member of the Cancer and Leukemia Group B (CALGB), National Surgical Adjuvant Breast Program (NSABP), Gynecologic Oncology Group (GOG), Radiation Therapy Oncology Group (RTOG) and the NCI sponsored Phase II Consortium. The program also actively participates in important industry-sponsored Phase I, II and III trials.